ABBV-383

A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • 23-193

Arms / Cohorts

Experimental:Arm A, Part 1: ABBV-383 Dose Escalation

Accepting patients

Experimental:Arm A, Part 2: ABBV-383 Dose Expansion

Accepting patients

Experimental:Arm B: ABBV-383 Dose Expansion

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.